Reactive Detection
Farmers observe symptoms – days after infection begins. By then, full herd exposure is complete. The window to act has already closed.
This platform contains proprietary and confidential information protected under NDA. Please read the agreement below and create your access credentials, or sign in as a returning investor.
CONFIDENTIAL NON-DISCLOSURE AGREEMENT
This Non-Disclosure Agreement ("Agreement") is entered into between Burmain Holdings (Pty) Ltd ("Disclosing Party") and the undersigned individual ("Receiving Party").
1. PURPOSE
The Receiving Party wishes to review confidential materials related to the
BovRes BR-1 BovResonator platform, HerdShield technology, and associated investment opportunity for the sole
purpose of evaluating a potential investment in Burmain Holdings (Pty) Ltd.
2. CONFIDENTIAL INFORMATION
Includes but is not limited to: proprietary technology
(SHEA Algorithm, biophoton sensing systems, scalar-wave broadcasting), financial projections, business
strategy, intellectual property, patent specifications, customer data, and all materials contained herein.
3. OBLIGATIONS
The Receiving Party agrees to: (a) maintain strict confidentiality; (b)
not reproduce, distribute, or disclose any information to third parties; (c) use the information solely for
investment evaluation purposes; (d) protect the information with at least the same degree of care used for
their own confidential information.
4. EXCLUSIONS
This Agreement does not apply to information that is: (a) publicly
available through no breach of this Agreement; (b) independently developed by the Receiving Party; (c)
rightfully received from a third party without restriction.
5. INTELLECTUAL PROPERTY
No license or rights to any intellectual property of Burmain
Holdings (Pty) Ltd are granted by this Agreement.
6. RETURN OF MATERIALS
Upon request, the Receiving Party shall promptly return or
destroy all confidential materials.
7. DURATION
This Agreement remains in effect for five (5) years from the date of
signing.
8. GOVERNING LAW
This Agreement is governed by the laws of the Republic of South
Africa.
9. ENTIRE AGREEMENT
This constitutes the entire agreement between the parties regarding
confidentiality of the subject matter herein. By proceeding, you confirm you have read, understood, and
agree to be bound by these terms.
Select your equity tier and submit your pledge. You'll receive a pre-filled investment agreement for review and countersignature.
Burmain Holdings (Pty) Ltd presents
BR-1 BovResonator detects Foot and Mouth Disease 48 hours before symptoms appear — then neutralizes it with precision scalar-wave technology. No chemicals. No culling. No trade restrictions.
Foot and Mouth Disease affects 77% of the world's livestock. A single confirmed outbreak triggers immediate export bans, destroys herd genetics, and costs R5M—R10M in direct losses. South Africa's R150 billion livestock industry relies on one response: reactive culling — an approach that destroys wealth, wipes out genetic lineage, and does nothing to prevent the next outbreak.
Farmers observe symptoms – days after infection begins. By then, full herd exposure is complete. The window to act has already closed.
A single FMD case triggers automatic international trade bans. Losses cascade beyond the infected farm — entire regional industries shut down.
Vaccines and antibiotics mask symptoms while building resistance and — critically — disqualifying herds from export certification protocols.
Culling eliminates irreplaceable genetic lineages valued at millions per animal. The cure is as destructive as the disease.
BR-1 BovResonator — a precision bio-digital collar that detects, alerts, and neutralizes Foot and Mouth Disease before it spreads. No chemicals. No export disruption. No genetic loss.
SHEA Algorithm broadcasts 180— phase-inverted frequencies to create destructive interference with the FMD virus frequency signature — neutralizing replication at the cellular level.
PMT-based Ultraweak Biophoton Emission sensors detect cellular oxidative stress 48 hours before physical symptoms appear — the earliest detection window in the industry.
Each collar broadcasts a 50-metre protective scalar field. Collars synchronize across the herd in <100ms, creating a collective immunity mesh network.
868/915 MHz long-range, low-power network operates without cellular coverage. Optional direct-to-satellite via LEO (Starlink) for remote stations.
Real-time traffic-light UX: Green = Healthy, Yellow = Alert, Red = Critical. Push notifications, GPS quarantine triggers, and automated intervention protocols.
BR-1 does not alter serological status. Herds remain export-certified during regional outbreaks — a unique competitive advantage worth billions in protected trade revenue.
Provisional patent filed. Core moat: the SHEA Algorithm paired with a proprietary biophoton frequency library — not replicable without the underlying physics and 18 months of calibration data.
Scalar-Homeopathic Encoding Algorithm. Caduceus-wound bifilar coils generate longitudinal scalar waves. Phase-inversion at 180— creates destructive interference with FMD's specific frequency signature.
Ultraweak Biophoton Emission via PMT sensors. Detects drop in cellular photon coherence — a measurable marker of oxidative stress — 48 hours before visible symptoms manifest.
Accelerometer-based lameness detection. AI model identifies weight-shifting patterns and stride asymmetry unique to early-stage FMD hoof lesion formation.
Measures skin electrical resistance. Viral replication causes measurable conductance drops across the coronary band and muzzle — tracked in real-time.
868/915 MHz mesh network. <100ms herd-wide synchronization latency. Optional direct-to-satellite (LEO) backhaul for off-grid farm stations.
AI-driven health logic automated via n8n workflow engine. Triggers alert, virtual fence quarantine, intervention protocol, and recovery monitoring without manual input.
Graphene-coated copper antenna achieves high-Q resonance for precision scalar broadcast. Supplied by SabiNano — South Africa's leading nanotech supplier.
Homeopathic remedy encoding (Variolinum 200C, Rhus Tox, Arsenicum Album) broadcast as scalar 'immune primers' to the healthy herd — 50m radius prophylactic field.
Physical
Power & Connectivity
Detection & AI
10 collars + Herd-Link Basic subscription — R15,000 — Ideal for small operations or pilot evaluation
100 collars + Herd-Link Pro (full AI automation) — R135,000 — Most popular for commercial dairy and feedlot operations
500+ collars + full SaaS stack + dedicated onboarding + custom SHEA calibration — Custom quote — For large feedlots and government biosecurity programs
FMD is endemic across 77% of the world's livestock territory. The global Precision Livestock Farming market exceeds $30 billion, growing at 1–5% CAGR. BovRes enters at the precise intersection of biotech, AI, and agriculture — where urgency meets capital.
$30B+ Global TAM — 1–5% CAGR — Rapid IoT/AI adoption across commercial farming
$8.2B addressable — Africa, Asia, South America, BRICS — 77% of global livestock population at risk
R4.5B market — Accelerating regulatory demand — DALRRD biosecurity modernization pipeline
–2x EBITDA acquisition multiples — Zoetis, Merck Animal Health, Elanco are active acquirers — – year exit horizon
REVENUE MODEL
Hardware margins fund SaaS growth. SaaS funds VaaS licensing. Each stream compounds the next.
BR-1 collar at R1,500 MSRP. R650 BOM. 75% gross margin. Production scales to 5,000 units in Year 2 with Series A capital.
Per-herd monthly subscription. Automated SHEA algorithm updates pushed via cloud. Recurring revenue grows with every active collar deployed.
Annual maintenance kits: graphene antenna ribbons, LiFePO4 battery packs, sensor calibration modules. High-margin, guaranteed recurring demand.
Vitality-as-a-Service: license the SHEA Algorithm and frequency library to existing livestock wearable manufacturers globally. Pure software margin at scale.
75% Gross Margin — Hardware
50,000 Target Units — Year 3
–2— EBITDA — AgTech Exit Multiple
THIRD-PARTY VALIDATION
IBM Watson Review
Ready for Pasture
Full technical review of the BR-1 stack completed. IBM Watson's verdict: technology is sound and market-ready for pilot deployment.
Grasslands Agriculture
50-Unit Pilot Confirmed
Letter of Support received from Grasslands Agriculture. 50-unit proof-of-concept trial confirmed for Q4 2026.
SabiNano — Graphene Supply
Letter of Intent Signed
SabiNano — South Africa's leading nanotech supplier — has signed a Letter of Intent for graphene ribbon supply to BovRes manufacturing.
MSRP R1,500 · BOM R650 · ~57% GM at production scale
R15M · Year 2 · 5,000-unit run · Full SaaS launch
12–20× EBITDA · Zoetis, Merck, Elanco active acquirers
Provisional patent · SHEA Algorithm · PCT filing in progress
R3.5M
Total Raise
Seed / Validation
Stage
75%
Gross Margin
–2— EBITDA
Exit Target
5%
Entry
R175K
8%
Growth
R280K
12%
Partner
R420K
18%
Strategic
R630K
25%
Lead
R875K
Receive your pre-filled Investment Agreement within 2 hours
THE TEAM
Founder & CEO, Burmain Holdings (Pty) Ltd
Embedded Hardware — ESP32 / AD9833 — PCB Design
Lead Physicist — SHEA Algorithm — Biophoton Validation — Scalar Field Theory
Digital Nosode Library — Remedy Encoding — Potency Calibration
Clinical Validation — IBM Watson Interface — FMD Protocol Design
Herd-Link PWA — n8n Orchestration — Database Architecture
ICASA — SABS — WOAH — DALRRD Compliance
Patent Strategy — PCT Filing — Global IP Co
THE WINDOW IS OPEN
The BR-1 seed round is live. 50-unit Grasslands Agriculture pilot confirmed. IBM Watson validated. Join the team redefining livestock biosecurity for the next century.
Headquarters
Techno Park, Stellenbosch, South Africa
Investor Relations
invest@bovres.com
Technical Enquiries
tech@bovres.com
Founder Direct
bd@burmain.com